{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:20:29Z","timestamp":1760239229426,"version":"build-2065373602"},"reference-count":51,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>First of all, we would like to thank all the authors for their contribution and the editorial staff who enabled the achievement of this \u201cManagement of Sarcoidosis: Challenges and Solutions\u201d Special Issue [...]<\/jats:p>","DOI":"10.3390\/jcm9103220","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T10:28:02Z","timestamp":1602066482000},"page":"3220","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of Sarcoidosis, a Selection of Topical Items Updating"],"prefix":"10.3390","volume":"9","author":[{"given":"Dominique","family":"Valeyre","sequence":"first","affiliation":[{"name":"UMR INSERM 1272 Universit\u00e9 Sorbonne Paris Nord, 93000 Bobigny, France"},{"name":"APHP H\u00f4pital Avicenne, 93000 Bobigny, France"},{"name":"Groupe Hospitalier Paris-Saint Joseph, 75014 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Bernaudin","sequence":"additional","affiliation":[{"name":"UMR INSERM 1272 Universit\u00e9 Sorbonne Paris Nord, 93000 Bobigny, France"},{"name":"APHP H\u00f4pital Avicenne, 93000 Bobigny, France"},{"name":"Facult\u00e9 de M\u00e9decine, Sorbonne Universit\u00e9, 75013 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3390\/jcm9082445","article-title":"Models Contribution to the Understanding of Sarcoidosis Pathogenesis: \u201cAre There Good Models of Sarcoidosis?\u201d","volume":"9","author":"Besnard","year":"2020","journal-title":"J. Clin. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.3390\/jcm9082633","article-title":"Current Insights in Genetics of Sarcoidosis: Functional and Clinical Impacts","volume":"9","author":"Calender","year":"2020","journal-title":"J. Clin. Med."},{"key":"ref_3","first-page":"2002695","article-title":"Phagosome-regulated mTOR Signalling during Sarcoidosis Granuloma Biogenesis","volume":"17","author":"Crouser","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ni.3655","article-title":"Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression","volume":"18","author":"Linke","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.it.2020.01.007","article-title":"Sarcoidosis and the TOR, Rac1, and Autophagy Triad","volume":"41","author":"Pacheco","year":"2020","journal-title":"Trends Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Gupta, N., Bleesing, J.H., and McCormack, F.X. (2020). Successful Response to Treatment with Sirolimus in Pulmonary Sarcoidosis. Am. J. Respir. Crit. Care Med., Online ahead of print.","DOI":"10.1164\/rccm.202004-0914IM"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1900119","DOI":"10.1183\/13993003.00119-2019","article-title":"The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation","volume":"55","author":"Huppertz","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0008-8749(87)90255-3","article-title":"Evaluation of alveolar macrophages in normals and individuals with active pulmonary sarcoidosis for the spontaneous expression of the interleukin-1 beta gene","volume":"107","author":"Wewers","year":"1987","journal-title":"Cell. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jclinpath-2016-203810","article-title":"Autoinflammatory diseases: Update on classification diagnosis and management","volume":"70","author":"Pathak","year":"2017","journal-title":"J. Clin. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2000149","DOI":"10.1183\/13993003.00149-2020","article-title":"In addition to mTOR and JAK\/STAT, NLRP3 inflammasome is another key pathway activated in sarcoidosis","volume":"55","author":"Riteau","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1800385","DOI":"10.1183\/13993003.00385-2018","article-title":"Familial aggregation and heritability of sarcoidosis: A Swedish nested case-control study","volume":"52","author":"Rossides","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1900430","DOI":"10.1183\/13993003.00430-2019","article-title":"Exome sequencing and pathogenicity-network analysis of five French families implicate mTOR signalling and autophagy in familial sarcoidosis","volume":"54","author":"Calender","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/MCP.0000000000000500","article-title":"Sarcoidosis and autoimmune diseases: Differences, similarities and overlaps","volume":"24","author":"Korsten","year":"2018","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000204339","article-title":"Multiple autoimmune diseases in sarcoidosis","volume":"91","author":"Papadopoulos","year":"1994","journal-title":"Acta Haematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MD.0b013e31822618b3","article-title":"Association of sarcoidosis and immune thrombocytopenia: Presentation and outcome in a series of 20 patients","volume":"90","author":"Chiche","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Baerlecken, N., Pursche, N., Witte, T., Kniesch, K., H\u00f6pfner, M., Ernst, D., Moosig, F., Seeliger, B., and Prasse, A. (2020). Presence of Antibodies Binding to Negative Elongation Factor E in Sarcoidosis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9030715"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1172\/JCI32401","article-title":"Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis","volume":"117","author":"Dengjel","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3389\/fimmu.2018.01516","article-title":"In Situ Humoral Immunity to Vimentin in HLA-DRB1*03Patients with Pulmonary Sarcoidosis","volume":"9","author":"Kinloch","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Eberhardt, C., Thillai, M., Parker, R., Siddiqui, N., Potiphar, L., Goldin, R., Timms, J.F., Wells, A.U., Kon, O.M., and Wickremasinghe, M. (2017). Proteomic Analysis of Kveim Reagent Identifies Targets of Cellular Immunity in Sarcoidosis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0170285"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF02890384","article-title":"Immunofluorescence microscopic demonstration of vimentin filaments in asteroid bodies of sarcoidosis. A comparison with electron microscopic findings","volume":"42","author":"Cain","year":"1983","journal-title":"Virchows Arch. B Cell Pathol. Incl. Mol. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"745","DOI":"10.15252\/embr.201643191","article-title":"NELF-E is recruited to DNA double-strand break sites to promote transcriptional repression and repair","volume":"18","author":"Awwad","year":"2017","journal-title":"EMBO Rep."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"McGonagle, D., and McDermott, M.F. (2006). A proposed classification of the immunological diseases. PLoS Med., 3.","DOI":"10.1371\/journal.pmed.0030297"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"McClain Caldwell, I., Hogden, C., Nemeth, K., Boyajian, M., Krepuska, M., Szombath, G., MacDonald, S., Abshari, M., Moss, J., and Vitale-Cross, L. (2020). Bone Marrow-Derived Mesenchymal Stromal Cells (MSCs) Modulate the Inflammatory Character of Alveolar Macrophages from Sarcoidosis Patients. J. Clin. Med., 9.","DOI":"10.3390\/jcm9010278"},{"key":"ref_24","first-page":"106","article-title":"Placenta-derived mesenchymal-like cells (PDA-001) as therapy for chronic pulmonary sarcoidosis: A phase 1 study","volume":"32","author":"Baughman","year":"2015","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.3389\/fimmu.2019.02265","article-title":"Metabolic Programming of Macrophages: Implications in the Pathogenesis of Granulomatous Disease","volume":"10","author":"Wilson","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccm.2015.08.016","article-title":"Cellular Players in the Immunopathogenesis of Sarcoidosis","volume":"36","author":"Zissel","year":"2015","journal-title":"Clin. Chest Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet (Lond. Engl.)"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","article-title":"Pulmonary sarcoidosis","volume":"6","author":"Spagnolo","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Moor, C.C., Kahlmann, V., Culver, D.A., and Wijsenbeek, M.S. (2020). Comprehensive Care for Patients with Sarcoidosis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020390"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1164\/rccm.201906-1250OC","article-title":"Income and Other Contributors to Poor Outcomes in U.S. Patients with Sarcoidosis","volume":"201","author":"Harper","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1183\/13993003.00477-2016","article-title":"Sarcoidosis incidence and prevalence: A nationwide register-based assessment in Sweden","volume":"48","author":"Arkema","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1183\/13993003.00457-2016","article-title":"Sarcoidosis-related mortality in France: A multiple-cause-of-death analysis","volume":"48","author":"Jamilloux","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1183\/23120541.00141-2018","article-title":"Sarcoidosis: Patient treatment priorities","volume":"4","author":"Baughman","year":"2018","journal-title":"ERJ Open Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"106081","DOI":"10.1016\/j.rmed.2020.106081","article-title":"Corticosteroid refractory sarcoidosis","volume":"171","author":"Goldman","year":"2020","journal-title":"Respir. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1702089","DOI":"10.1183\/13993003.02089-2017","article-title":"Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis","volume":"51","author":"Broos","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.rmed.2017.10.022","article-title":"No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis","volume":"138S","author":"Broos","year":"2018","journal-title":"Respir. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.chest.2016.08.1457","article-title":"Cardiac Sarcoidosis: The Impact of Age and Implanted Devices on Survival","volume":"151","author":"Zhou","year":"2017","journal-title":"Chest"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Jain, R., Yadav, D., Puranik, N., Guleria, R., and Jin, J.O. (2020). Sarcoidosis: Causes, Diagnosis, Clinical Features, and Treatments. J. Clin. Med., 9.","DOI":"10.3390\/jcm9041081"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Keijsers, R.G.M., and Grutters, J.C. (2020). In Which Patients with Sarcoidosis Is FDG PET\/CT Indicated?. J. Clin. Med., 9.","DOI":"10.3390\/jcm9030890"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Sawahata, M., Johkoh, T., Kawanobe, T., Kono, C., Nakamura, Y., Bando, M., Hagiwara, K., Takemura, T., Sakai, F., and Shijubo, N. (2020). Computed Tomography Images of Fibrotic Pulmonary Sarcoidosis Leading to Chronic Respiratory Failure. J. Clin. Med., 9.","DOI":"10.3390\/jcm9010142"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.rmed.2018.08.008","article-title":"Sarcoidosis and IPF in the same patient-a coincidence, an association or a phenotype?","volume":"144S","author":"Collins","year":"2018","journal-title":"Respir. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/thoraxjnl-2015-206825","article-title":"Lung sarcoidosis in children: Update on disease expression and management","volume":"70","author":"Nathan","year":"2015","journal-title":"Thorax"},{"key":"ref_44","first-page":"53","article-title":"Paediatric sarcoidosis","volume":"29","author":"Nathan","year":"2019","journal-title":"Paediatr. Respir. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Chauveau, S., Jeny, F., Montagne, M.E., Taam, R.A., Houdouin, V., Meinzer, U., Delacourt, C., Epaud, R., Aubart, F.C., and Chapelon-Abric, C. (2020). Child-Adult Transition in Sarcoidosis: A Series of 52 Patients. J. Clin. Med., 9.","DOI":"10.3390\/jcm9072097"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Pedro, C., Melo, N., Novais e Bastos, H., Magalh\u00e3es, A., Fernandes, G., Martins, N., Morais, A., and Caetano Mota, P. (2019). Role of Bronchoscopic Techniques in the Diagnosis of Thoracic Sarcoidosis. J. Clin. Med., 8.","DOI":"10.3390\/jcm8091327"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1183\/23120541.00203-2019","article-title":"Diagnostic yield and safety of transbronchial cryobiopsy in sarcoidosis","volume":"5","author":"Jacob","year":"2019","journal-title":"ERJ Open Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1600746","DOI":"10.1183\/13993003.00746-2016","article-title":"Atopobium and Fusobacterium as novel candidates for sarcoidosis-associated microbiota","volume":"50","author":"Zimmermann","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1700991","DOI":"10.1183\/13993003.00991-2017","article-title":"Phenotypes of organ involvement in sarcoidosis","volume":"51","author":"Schupp","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Lhote, R., Annesi-Maesano, I., Nunes, H., Launay, D., Borie, R., Sacr\u00e9, K., Schleinitz, N., Hamidou, M., Mahevas, M., and Devilliers, H. (2020). Clinical phenotypes of extrapulmonary sarcoidosis: An analysis of a French, multiethnic, multicenter cohort. Eur. Respir. J., in press.","DOI":"10.1183\/13993003.01160-2020"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/10\/3220\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:17:12Z","timestamp":1760177832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/10\/3220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["jcm9103220"],"URL":"https:\/\/doi.org\/10.3390\/jcm9103220","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2020,10,7]]}}}